Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia.
about
Botulinum toxinUse of Botulinum Toxin A in the Treatment of Lower Urinary Tract Disorders: A Review of the LiteratureConsiderations on patient-related outcomes with the use of botulinum toxins: is switching products safe?Conversion Ratio between Botox®, Dysport®, and Xeomin® in Clinical PracticePharmacotherapy for the management of achalasia: Current status, challenges and future directionsClinical relevance of botulinum toxin immunogenicityCurrent and future medical treatment in primary dystonia.Systematic review and meta-analysis of the duration of clinical effect of onabotulinumtoxinA in cervical dystonia.DystoniaBotulinum toxin type A products are not interchangeable: a review of the evidence.Dystonia rating scales: critique and recommendationsBotulinum toxin: bioweapon & magic drugProfile of Xeomin® (incobotulinumtoxinA) for the treatment of blepharospasmDysport and Botox at a ratio of 2.5:1 units in cervical dystonia: a double-blind, randomized study.A new treatment for focal dystonias: incobotulinumtoxinA (Xeomin®), a botulinum neurotoxin type A free from complexing proteinsOnabotulinumtoxinA and AbobotulinumtoxinA Dose Conversion: a Systematic Literature ReviewFactors influencing response to Botulinum toxin type A in patients with idiopathic cervical dystonia: results from an international observational study.Practical guidance for CD management involving treatment of botulinum toxin: a consensus statement.Treatment of focal dystonias with botulinum neurotoxin.Onset and duration of effect of incobotulinumtoxinA, onabotulinumtoxinA, and abobotulinumtoxinA in the treatment of glabellar frown lines: a randomized, double-blind study.Efficacy of Onabotulinum Toxin A (Botox) versus Abobotulinum Toxin A (Dysport) Using a Conversion Factor (1 : 2.5) in Treatment of Primary Palmar HyperhidrosisUnmet Needs in the Management of Cervical DystoniaBotulinum toxin type A in the treatment of patients with cervical dystoniaClinical Practice: Evidence-Based Recommendations for the Treatment of Cervical Dystonia with Botulinum Toxin.Clinical Characteristics and Response to Long-Term Botulinum Toxin Type A Therapy in Patients with Cervical Dystonia at a Neurology Clinic.Diffusion of botulinum toxinsPain Relief in Cervical Dystonia with Botulinum Toxin Treatment.Abobotulinum Toxin A in the Treatment of Chronic Low Back PainGuidelines for the use of botulinum toxin in movement disorders and spasticity.Pharmacological differences and clinical implications of various botulinum toxin preparations: a critical appraisal.Botulinum Toxin Type A Injection for Cervical Dystonia in Adults with Dyskinetic Cerebral Palsy.Botulinum neurotoxin formulations: overcoming the confusion.
P2860
Q24634441-29AC4571-FEEF-4654-A378-E8D079A3AD80Q26749613-0F8C7A7A-E4FC-4F25-B161-955691EABDC5Q26766284-0BA6BAD8-444D-4F2C-B052-6A2989DC00ABQ26766728-A131B495-4619-4000-8A27-3AB683A09141Q26777632-9444872A-44D2-48D4-9900-16A5A5DA8E37Q26824771-8564D539-B9A2-4842-980E-BF57EA19EB31Q30465848-AD6E08E1-69EC-4B9D-B567-63D5C081C843Q33581389-1BB5C6CC-F2B9-48D3-9347-7C412ABE9CDAQ33929742-4086EF50-558C-4BA3-B664-860E8038FF26Q34352934-E49184A6-AB59-4CD2-B092-5633275729B3Q34393230-D661108A-A88A-4AF1-A345-FF5F6AD3B88EQ34530009-3972E2A4-87A3-4787-B361-8914FCBA5233Q35050218-F47B7CD7-B5CD-4047-83A9-2579F9AF1615Q35175351-372BCADF-2D83-4D21-99CD-0E8504600644Q35681898-1A89C30C-118A-4290-BB3B-72993DC1039FQ35997976-A68D9FEC-48DF-47DD-92E2-0BCA427013EFQ36045061-1722B9AA-6E9B-4DE2-9220-52AE4C99EC2AQ36171693-AEEA6BE1-BF07-4197-81E7-D5EEAE74CAE0Q36662999-61C9D247-EBC4-42D7-B280-F479BB3305C8Q37213172-6DEA03D7-E297-4188-92D8-08F85AB90CEBQ37286003-BB023116-7B33-4555-B7D0-215FF146463FQ37289941-3682B7A7-96A8-4B68-A67F-262C6FE62E1EQ37586904-B1EFA449-1BFA-43ED-AEF7-25F168FA0CAEQ37662597-02AD2EE6-0395-4222-A512-C62777201795Q37704010-8C5D7DF7-08A0-4D17-9F00-83237DFD492FQ38084574-DA678B2B-77D8-4AD2-AE22-76B3DF98FFCDQ38537633-B32BA059-759B-42DF-B994-4E90ED7142F3Q39095007-3A04F103-699F-4884-AA16-AC998BF93CB8Q42180898-C0C53BD5-9FCB-465B-9585-8A544CF3828DQ55039946-3B9BBDDF-3D05-4814-A06B-E46FDA6B8828Q55250949-DF3DA004-1036-4D78-B5DA-06EC3509E89FQ55260245-BEC15761-12CA-4817-B8E0-B7DFE2F9EBEC
P2860
Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia.
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Respective potencies of Botox ...... er study in cervical dystonia.
@ast
Respective potencies of Botox ...... er study in cervical dystonia.
@en
type
label
Respective potencies of Botox ...... er study in cervical dystonia.
@ast
Respective potencies of Botox ...... er study in cervical dystonia.
@en
prefLabel
Respective potencies of Botox ...... er study in cervical dystonia.
@ast
Respective potencies of Botox ...... er study in cervical dystonia.
@en
P2093
P2860
P356
P1476
Respective potencies of Botox ...... ver study in cervical dystonia
@en
P2093
P2860
P304
P356
10.1136/JNNP.72.4.459
P407
P577
2002-04-01T00:00:00Z